The invention relates to peptidic compounds, which peptidic compounds are compounds of formula (I)′, or a pharmaceutically acceptable salt, or solvate, or N-oxide, or stereoisomer thereof:
wherein R
1
; R
2
; s; t; u; Aa
78
and G
1
are as defined herein.
The peptidic compounds are useful in activating the Nrf2 pathway.
[EN] NOVEL COMPOUNDS ACTIVATING THE NRF2 PATHWAY<br/>[FR] NOUVEAUX COMPOSÉS ACTIVANT LA VOIE NRF2
申请人:ALMIRALL SA
公开号:WO2019030298A1
公开(公告)日:2019-02-14
The invention relates to peptidic compounds, which peptidic compounds are compounds of formula (I)', or a pharmaceutically acceptable salt, or solvate, or N-oxide, or stereoisomer thereof: (I)', wherein R1; R2; s; t; u; Aa78 and G1 are as defined herein. The peptidic compounds are useful in activating the Nrf2 pathway.